Healthcare


Government Survey

2018 US Politics - 45% of all Americans approve the job their individual representative is doing (November 21th)

Ahead of Thanksgiving weekend, Congress enjoys a slight bump in approval.
Government Survey

2018 US Politics - 23% of Americans report that healthcare is the most important problem facing the US today (November 14)

Following the midterm elections, President Trump's approval rating remains steady.
Healthcare Publication

Connected Health Trends 2018

Connected Health: moving in the right direction.

What Worries the World - September 2018

New global poll finds four concerns top the world’s worry list: Unemployment, poverty/social inequality, crime/violence and financial/political corruption.
Healthcare Event

[EVENT] ISPOR Europe 2018

November 12-14 - Join Ipsos at ISPOR – the leading European conference for health economics and outcomes research.
Patients Event

[EVENT] Transforming Healthcare through Patient Experience

November 8 - How do we give patients the best care possible to promote the best health possible? Thought leaders, hospital administrators, and providers will come together in this symposium to talk about how they have transformed healthcare for the good of the patient.
Politics Survey

2018 US Politics - 42% of Americans Approving of Trump's Job as President (September 19)

Among all Americans, Democrats (39%) hold an 8-point lead over Republicans (31%) in this week's generic congressional ballot.
Healthcare Publication

Targeting the Affluent: Differential Access to Targeted Therapies in China

Conquering Complexity, at a Price. This paper will illustrate how disparities in income levels continue to drive far-reaching differences in the way poorer and richer Chinese with cancer are being treated for their disease.
Patients Publication

The Path to Patient Centricity: Closing the 'How' Gap

Today, patient centricity is not only well documented in corporate visions and missions, it’s at the top of many pharmaceutical company agendas. Clearly, there is both a need for it and an appetite for it among those best placed to make it happen. The question that remains for pharma and biotechs is how best to be patient-centric…